MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 34 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $108,000 | -30.3% | 18,704 | -18.9% | 0.00% | – |
| Q4 2020 | $155,000 | -8.3% | 23,065 | 0.0% | 0.00% | – |
| Q3 2020 | $169,000 | +94.3% | 23,065 | 0.0% | 0.00% | – |
| Q2 2020 | $87,000 | +107.1% | 23,065 | 0.0% | 0.00% | – |
| Q1 2020 | $42,000 | -92.8% | 23,065 | -36.4% | 0.00% | -100.0% |
| Q4 2019 | $581,000 | -7.3% | 36,265 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $627,000 | – | 36,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |